Perioperative clopidogrel (Plavix) continuation in shoulder arthroplasty: approach cautiously.

JSES Int · 2022 · PMC9091745 · PMID 35572450

Europe PMC DOI

hedged sentence

0.4600

closest p · 9.2× alpha

0.4600

boldest claim

The sentences

did not reach statistical significanceP = .46not close (p > 0.1)

The 30-day ACE rate was 0 of 20 patients in group 1 (clopidogrel continued) compared to 1 of 37 (3%) patients in group 2 (clopidogrel held), and this difference did not reach statistical significance ( P = .46).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.